Just checked things.
Whilst not entirely correct, what i had done was assume that the entire "other receivables and prepayments" balance of $1,855K related to the Townsville contract , and was more like $2M when it started. As such, being a 5 year contract i assumed it would be drawn down over 20 quarters at a rate of $100k per quarter. As at April 1st, i had ~$2780k trade receivables + $1,600k balance of Townsville. I am therefore expecting cash receipts of $2780 + 45% x forecast revenue of $6370 (which may be a little optimistic) +100k from townsville = ~$5,735
The purpose of my cashflow model was to see if i thought cash reserves would dip to the point where they would require a capital raising so i didn't get too fussy about being too precise. I'm sure adjusting the receivables balance for 'prepayments and security deposits' would yield a slightly different result, but i deemed it immaterial for the purpose of the "do we need a CR" exercise.
Regarding the "other income" in the March, 4C.... i have no idea, but i look forward to managements response. I note they elected not to comment, even though the 4C states "provide details if material"
- Forums
- ASX - By Stock
- AVR
- AHZ Accounting
AHZ Accounting, page-53
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$18.35 |
Change
0.000(0.00%) |
Mkt cap ! $352.7M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 225 | $18.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.50 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 225 | 18.360 |
2 | 383 | 18.130 |
1 | 300 | 18.110 |
1 | 1000 | 18.000 |
1 | 55 | 17.910 |
Price($) | Vol. | No. |
---|---|---|
18.500 | 1000 | 1 |
19.000 | 437 | 1 |
19.700 | 100 | 1 |
19.870 | 202 | 1 |
20.000 | 3400 | 5 |
Last trade - 08.47am 03/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online